Glycoconjugates are stage- and position-specific cell surface molecules in the developing olfactory system, 1: The CC1 immunoreactive glycolipid defines a rostrocaudal gradient in the rat vomeronasal system.
Primary sensory neurons in the vomeronasal organ (VNO) project axons to the glomeruli of the accessory olfactory bulb (AOB) where they form connections with mitral cell dendrites. We demonstrate here that monoclonal antibodies to specific carbohydrate antigens define stage- and position-specific events during the development of the vomeronasal system (VN). CC1 monoclonal antibodies react with specific N-acetyl galactosamine containing glycolipids. In the embryo, CC1 antigens are expressed throughout the VNO and on vomeronasal nerves. Beginning approximately at birth and continuing into adults, CC1 expression is spatially restricted in the VNO to centrally located cell bodies. In the postnatal AOB, CC1 is expressed in the nerve layer and glomeruli, but only in the rostral half of the AOB. These data suggest that CC1 antigens may participate in the targeting of axons from centrally located VNO neurons to rostral glomeruli in the AOB. In contrast, CC2 monoclonal antibodies, which recognize complex alpha-galactosyl and alpha-fucosyl glycoproteins and glycolipids, react with all VNO cell bodies and VN nerves from embryonic (E) day 15 to adults. CC2 antibodies do not distinguish rostral from caudal regions of the AOB, nor are the CC2 glycoconjugates developmentally regulated. P-Path monoclonal antibodies, which recognize 9-O-acetyl sialic acid, react with cell bodies in the VNO and nerve fibers from E13 to postnatal (P) day 2. P-Path immunoreactivity disappears from the VNO system almost completely by P14, when only a few P-Path reactive nerve fibers can be seen. These studies suggest that specific cell surface glycoconjugates may participate in spatially and temporally selective cell-cell interactions during development and maintenance of vomeronasal connections.
Schwarting
G A
GA
Department of Biochemistry, E. K. Shriver Center, Waltham, Massachusetts 02254.
Deutsch
G
G
Gattey
D M
DM
Crandall
J E
JE
D000818:Animals; D000911:Antibodies, Monoclonal; D002241:Carbohydrates / Q000276:immunology; D002478:Cells, Cultured; D000939:Epitopes / Q000032:analysis; D005260:Female; D005455:Fluorescent Antibody Technique; D006001:Glycoconjugates / Q000032:analysis*; D006017:Glycolipids / Q000032:analysis*; D008297:Male; D008563:Membrane Lipids / Q000032:analysis*; D009295:Nasal Bone / Q000737:chemistry* / Q000196:embryology / Q000254:growth & development; D009300:Nasal Septum / Q000737:chemistry* / Q000196:embryology / Q000254:growth & development; D009474:Neurons / Q000737:chemistry; D009830:Olfactory Bulb / Q000737:chemistry* / Q000196:embryology / Q000254:growth & development; D051381:Rats; D011919:Rats, Inbred Strains
D000911:Antibodies, Monoclonal; D002241:Carbohydrates; D000939:Epitopes; D006001:Glycoconjugates; D006017:Glycolipids; D008563:Membrane Lipids